aTyr Pharma | LIFE - Ebitda





Ebitda Alterar Data
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Ardelyx USD -29.77M 35.79M 2026-03
aTyr Pharma USD -54K 25.9M 2026-03
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Cipla INR 9.55B 3B 2026-03
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -9.02M 1.12M 2026-03
CSL USD 3.13B 1.17B 2025-12
Curis USD -12.3M 231K 2023-09
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Grifols EUR 482.04M 7.04M 2025-09
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Novartis USD 5.3B 530M 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
United Therapeutics USD 379.5M 83.4M 2025-12
Xoma USD 2.52M 7.98M 2024-06